Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

January 23, 2015 09:00 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Announces Date of FDA Advisory Committee Review of ATX-101 for the Treatment of Submental Fullness

WESTLAKE VILLAGE, Calif., Jan. 23, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced the Dermatology and Ophthalmic Drugs Advisory Committee of the U.S. Food and...
January 20, 2015 20:47 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program

WESTLAKE VILLAGE, Calif., Jan. 20, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on January 16, 2015, the Compensation Committee of the Company's Board...
January 05, 2015 20:37 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Present at the 33rd Annual J.P. Morgan Healthcare Conference

WESTLAKE VILLAGE, Calif., Jan. 5, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at the...
January 05, 2015 16:10 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Appoints Hollings C. Renton to Board of Directors

WESTLAKE VILLAGE, Calif., Jan. 5, 2015 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that it has named Hollings C. Renton to its Board of Directors. Mr. Renton...
December 12, 2014 20:20 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program

WESTLAKE VILLAGE, Calif., Dec. 12, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that the Compensation Committee of the Company's Board of Directors granted...
November 14, 2014 17:18 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Present at the Goldman Sachs US Emerging / SMID Cap Growth Conference

WESTLAKE VILLAGE, Calif., Nov. 14, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that Keith Leonard, president and chief executive officer, will present at...
November 10, 2014 16:05 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Releases Third Quarter 2014 Operating Results

WESTLAKE VILLAGE, Calif., Nov. 10, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today reported financial results for its third quarter 2014 and provided an update on recent...
November 04, 2014 20:16 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program

WESTLAKE VILLAGE, Calif., Nov. 4, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on October 31, 2014, the Compensation Committee of the Company's Board of...
November 03, 2014 16:46 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals to Release Third Quarter 2014 Operating Results

WESTLAKE VILLAGE, Calif., Nov. 3, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced it will release its third quarter 2014 operating results and will host an...
October 21, 2014 17:34 ET | Source: KYTHERA Biopharmaceuticals, Inc.

KYTHERA Biopharmaceuticals Grants Stock Options Under Inducement Program

WESTLAKE VILLAGE, Calif., Oct. 21, 2014 (GLOBE NEWSWIRE) -- KYTHERA Biopharmaceuticals, Inc. (Nasdaq:KYTH) today announced that on October 17, 2014, the Compensation Committee of the Company's Board...